JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Get Free Report) was the target of a significant drop in short interest in the month of March. As of March 13th, there was short interest totaling 22,054 shares, a drop of 67.8% from the February 26th total of 68,506 shares. Based on an average trading volume of 8,890 shares, the days-to-cover ratio is presently 2.5 days. Currently, 0.3% of the shares of the company are sold short. Currently, 0.3% of the shares of the company are sold short. Based on an average trading volume of 8,890 shares, the days-to-cover ratio is presently 2.5 days.
Institutional Investors Weigh In On JLens 500 Jewish Advocacy U.S. ETF
An institutional investor recently bought a new position in JLens 500 Jewish Advocacy U.S. ETF stock. JPMorgan Chase & Co. purchased a new stake in JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 887 shares of the company’s stock, valued at approximately $25,000.
JLens 500 Jewish Advocacy U.S. ETF Price Performance
NYSEARCA TOV remained flat at $27.55 during trading on Wednesday. 819 shares of the company’s stock were exchanged, compared to its average volume of 8,043. The stock has a market cap of $198.36 million, a price-to-earnings ratio of 25.69 and a beta of 1.00. JLens 500 Jewish Advocacy U.S. ETF has a 52-week low of $20.40 and a 52-week high of $29.92. The company has a 50 day moving average of $28.67 and a 200 day moving average of $28.51.
JLens 500 Jewish Advocacy U.S. ETF Company Profile
The JLens 500 Jewish Advocacy U.S. ETF (TOV) is an exchange-traded fund that is based on the JLens 500 Jewish Advocacy U.S. index. The fund tracks an index of large-cap US stocks while employing a methodology that seeks to align stock selection and weighting with Jewish value pillars. TOV was launched on Feb 26, 2025 and is issued by JLens.
Recommended Stories
Receive News & Ratings for JLens 500 Jewish Advocacy U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JLens 500 Jewish Advocacy U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
